Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Microdosing GLP-1 Medications: Complete Guide to Split Dosing
hubEverything you need to know about microdosing GLP-1 agonists. Split dosing protocols for retatrutide, tirzepatide, and semaglutide to reduce side effects without sacrificing weight loss results.
Retatrutide (GLP-3) Dosing Guide: 2mg to 12mg Protocol
guidesComplete GLP-3 retatrutide dosage guide covering the 2mg to 12mg weekly titration protocol, printable dosing chart, half-life pharmacokinetics, weight loss results from clinical trials, side effects management, and a free interactive dosing calculator.
Microdosing GLP-1 Side Effects: What the Dose-Response Data Shows
side-effectsA pharmacokinetics-anchored look at microdosing GLP-1 side effects across semaglutide, tirzepatide, and retatrutide: what trial dose-response data tells us about lower-dose GI tolerability, and which class-level serious risks persist at every dose.
Complete Tirzepatide Dosing Guide (2026)
guidesEverything you need to know about tirzepatide dosing: dual-agonist mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and dosing calculator.
Wegovy Pill Side Effects: What the FDA Label Reports
side-effectsThe oral Wegovy tablet carries the same GLP-1 side effect profile as the rest of the class, but the FDA label handles it differently from the injection. The pen gets a full per-symptom adverse reaction table. The tablet does not. This guide covers what the label actually reports for each format, the dose-ladder timing of GI symptoms, discontinuation rates, the boxed warning, and management strategies.
Complete Semaglutide Dosing Guide (2026)
guidesEverything you need to know about semaglutide dosing: GLP-1 mechanism, clinical trial efficacy data, starting dose through maintenance, titration schedules, half-life pharmacokinetics, side effects, and how to use a dosing calculator.